Company intelligence / Profile preview

Attest BioSciences

Alpharetta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Attest BioSciences has commercially launched its flagship at-home cancer screening test capable of detecting a specific biomarker present in multiple cancer types using a home sampling model. The company also offers additional at-home health tests for cardiac, diabetes, allergy, and STD/STI monitoring, but no published clinical trial results were found.

Therapeutic areas: CardiovascularImmunologyEndocrinologyInfectious DiseasesOncology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Attest BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Attest BioSciences.

Explore the full profile